TP53 and hepatocellular carcinoma: Sensitization of Hep3B, Huh7, and HepG2 cell lines to radiotherapy and chemotherapy was demonstrated following the treatment with AZD1775 in hepatocellular carcinoma regardless of their p53 mutational status25.